Seminar Series | Brussels, Belgium
Building momentum
in mRNA
From discovery through clinical trials
Seminar Series | Brussels, Belgium
Building momentum
in mRNA
From discovery through clinical trials
Seminar highlights | Brussels, Belgium
When
24 September, 2024
14:00 - 17:00
Networking hour after the seminar with refreshments
Where
Fee: No Cost.
Limited Seats.
Register below.
Unable to attend? Check out the date of our other seminar in Paris.
Agenda
MEVs: harnessing the full potential of RNAs, beyond vaccines and liver-targeted delivery - breaking past LNP constraints
Manuel Vega, PhD
CEO, AGS Therapeutics
Novel Synthetic DNA for production of mRNA Therapies and Vaccines
Ashish Dhir, PhD
Head of RNA, 4basebio
Journey through the world of RNA vaccines and therapeutics | Explore saRNA, CRISPR, and modified nucleotides
Kate Broderick, PhD
Chief Innovation Officer, Maravai LifeSciences
Getting started with mRNA–Increasing your probability for success
Vicky Smith, PhD
Technical program designer, TriLink Biotechnologies
Questions?
Email us at marketing@trilinkbiotech.com
TriLink BioTechnologies does not sell or distribute your information to third parties. For more information, please refer to our Privacy Policy